Stock Track | Phreesia Soars 5.13% Pre-Market as Q3 Results Beat Estimates and Guidance Raised

Stock Track12-10

Phreesia, Inc. (NYSE: PHR), a leading healthcare technology company, saw its stock soar 5.13% in pre-market trading on Tuesday. This surge can be attributed to the company's impressive third-quarter fiscal 2025 results and an optimistic outlook for the upcoming fiscal year.

In its earnings report, Phreesia announced a 17% year-over-year increase in revenue, reaching $106.8 million. The company also reported positive adjusted EBITDA of $9.8 million, a significant improvement of $16.4 million compared to the previous year. Additionally, Phreesia achieved positive operating cash flow of $5.8 million and free cash flow of $1.6 million, further strengthening its financial position.

Encouraged by the strong performance, Phreesia raised its fiscal 2025 adjusted EBITDA guidance to a range of $34 million to $36 million, up from the previous range of $26 million to $31 million. Furthermore, the company provided an optimistic outlook for fiscal 2026, expecting revenue to grow by 13% to 15% and adjusted EBITDA to increase by a staggering 129% to 144%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment